226 related articles for article (PubMed ID: 19955313)
1. Interferon-induced protection against foot-and-mouth disease virus infection correlates with enhanced tissue-specific innate immune cell infiltration and interferon-stimulated gene expression.
Diaz-San Segundo F; Moraes MP; de Los Santos T; Dias CC; Grubman MJ
J Virol; 2010 Feb; 84(4):2063-77. PubMed ID: 19955313
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antiviral activity against foot-and-mouth disease virus by a combination of type I and II porcine interferons.
Moraes MP; de Los Santos T; Koster M; Turecek T; Wang H; Andreyev VG; Grubman MJ
J Virol; 2007 Jul; 81(13):7124-35. PubMed ID: 17459931
[TBL] [Abstract][Full Text] [Related]
3. Constitutively Active IRF7/IRF3 Fusion Protein Completely Protects Swine against Foot-and-Mouth Disease.
Ramírez-Carvajal L; Diaz-San Segundo F; Ramirez-Medina E; Rodríguez LL; de Los Santos T
J Virol; 2016 Oct; 90(19):8809-21. PubMed ID: 27466421
[TBL] [Abstract][Full Text] [Related]
4. Immediate protection of swine from foot-and-mouth disease: a combination of adenoviruses expressing interferon alpha and a foot-and-mouth disease virus subunit vaccine.
Moraes MP; Chinsangaram J; Brum MC; Grubman MJ
Vaccine; 2003 Dec; 22(2):268-79. PubMed ID: 14615155
[TBL] [Abstract][Full Text] [Related]
5. Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.
Ramírez-Carvajal L; Díaz-San Segundo F; Hickman D; Long CR; Zhu J; Rodríguez LL; de los Santos T
J Virol; 2014 Oct; 88(19):11140-53. PubMed ID: 25031341
[TBL] [Abstract][Full Text] [Related]
6. Novel viral disease control strategy: adenovirus expressing alpha interferon rapidly protects swine from foot-and-mouth disease.
Chinsangaram J; Moraes MP; Koster M; Grubman MJ
J Virol; 2003 Jan; 77(2):1621-5. PubMed ID: 12502879
[TBL] [Abstract][Full Text] [Related]
7. Bovine type III interferon significantly delays and reduces the severity of foot-and-mouth disease in cattle.
Perez-Martin E; Weiss M; Diaz-San Segundo F; Pacheco JM; Arzt J; Grubman MJ; de los Santos T
J Virol; 2012 Apr; 86(8):4477-87. PubMed ID: 22301155
[TBL] [Abstract][Full Text] [Related]
8. Robust Protection against Highly Virulent Foot-and-Mouth Disease Virus in Swine by Combination Treatment with Recombinant Adenoviruses Expressing Porcine Alpha and Gamma Interferons and Multiple Small Interfering RNAs.
Kim SM; Park JH; Lee KN; Kim SK; You SH; Kim T; Tark D; Lee HS; Seo MG; Kim B
J Virol; 2015 Aug; 89(16):8267-79. PubMed ID: 26041279
[TBL] [Abstract][Full Text] [Related]
9. Porcine type I interferon rapidly protects swine against challenge with multiple serotypes of foot-and-mouth disease virus.
Dias CC; Moraes MP; Segundo FD; de los Santos T; Grubman MJ
J Interferon Cytokine Res; 2011 Feb; 31(2):227-36. PubMed ID: 20874428
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated type I interferon expression delays and reduces disease signs in cattle challenged with foot-and-mouth disease virus.
Wu Q; Brum MC; Caron L; Koster M; Grubman MJ
J Interferon Cytokine Res; 2003 Jul; 23(7):359-68. PubMed ID: 14511462
[TBL] [Abstract][Full Text] [Related]
11. Combined administration of synthetic RNA and a conventional vaccine improves immune responses and protection against foot-and-mouth disease virus in swine.
Borrego B; Blanco E; Rodríguez Pulido M; Mateos F; Lorenzo G; Cardillo S; Smitsaart E; Sobrino F; Sáiz M
Antiviral Res; 2017 Jun; 142():30-36. PubMed ID: 28315707
[TBL] [Abstract][Full Text] [Related]
12. Novel antiviral therapeutics to control foot-and-mouth disease.
Dias CC; Moraes MP; Weiss M; Diaz-San Segundo F; Perez-Martin E; Salazar AM; de los Santos T; Grubman MJ
J Interferon Cytokine Res; 2012 Oct; 32(10):462-73. PubMed ID: 22924938
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
[TBL] [Abstract][Full Text] [Related]
14. A recombinant adenovirus bicistronically expressing porcine interferon-α and interferon-γ enhances antiviral effects against foot-and-mouth disease virus.
Kim SM; Kim SK; Park JH; Lee KN; Ko YJ; Lee HS; Seo MG; Shin YK; Kim B
Antiviral Res; 2014 Apr; 104():52-8. PubMed ID: 24485895
[TBL] [Abstract][Full Text] [Related]
15. Loss of plasmacytoid dendritic cell function coincides with lymphopenia and viremia during foot-and-mouth disease virus infection.
Nfon CK; Toka FN; Kenney M; Pacheco JM; Golde WT
Viral Immunol; 2010 Feb; 23(1):29-41. PubMed ID: 20121400
[TBL] [Abstract][Full Text] [Related]
16. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
Pena L; Moraes MP; Koster M; Burrage T; Pacheco JM; Segundo FD; Grubman MJ
Vaccine; 2008 Oct; 26(45):5689-99. PubMed ID: 18762225
[TBL] [Abstract][Full Text] [Related]
17. Venezuelan equine encephalitis replicon particles can induce rapid protection against foot-and-mouth disease virus.
Diaz-San Segundo F; Dias CC; Moraes MP; Weiss M; Perez-Martin E; Owens G; Custer M; Kamrud K; de los Santos T; Grubman MJ
J Virol; 2013 May; 87(10):5447-60. PubMed ID: 23468490
[TBL] [Abstract][Full Text] [Related]
18. Type III interferon protects swine against foot-and-mouth disease.
Perez-Martin E; Diaz-San Segundo F; Weiss M; Sturza DF; Dias CC; Ramirez-Medina E; Grubman MJ; de los Santos T
J Interferon Cytokine Res; 2014 Oct; 34(10):810-21. PubMed ID: 24786495
[TBL] [Abstract][Full Text] [Related]
19. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.
Moraes MP; Mayr GA; Mason PW; Grubman MJ
Vaccine; 2002 Feb; 20(11-12):1631-9. PubMed ID: 11858872
[TBL] [Abstract][Full Text] [Related]
20. Alpha interferon is a powerful adjuvant for a recombinant protein vaccine against foot-and-mouth disease virus in swine, and an effective stimulus of in vivo immune response.
Cheng G; Zhao X; Yan W; Wang W; Zuo X; Huang K; Liu Y; Chen J; Wang J; Cong W; Liu M; Gao H; Chen J; Lu Y; Zheng Z
Vaccine; 2007 Jul; 25(28):5199-208. PubMed ID: 17555848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
